Evidence map›Paper›PMID 41069501›Full record

ArticleJournal of public health in Africa2025

Strengthening community engagement in the fight against hepatitis B in two regions of Cameroon.

Solange Neh Manju Atah, Nadege Goumkwa Mafopa, Cindy Lobe, Juliette-Laure N Ndzie Ondigui, Jude S Y Atah, Joseph Nelson Siewe Fodjo, Patrick Awoumou, Alliance-Laure Otam, Martin N D Mokake, Puinta Peyonga and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of public health in Africa, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Solange Neh Manju AtahDepartment of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.ORCID https://orcid.org/0009-0004-5602-2329
Nadege Goumkwa MafopaDepartment of Molecular Biology, Chantal BIYA International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.ORCID https://orcid.org/0009-0007-2379-6688
Cindy LobeDepartment of Molecular Biology, Chantal BIYA International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.ORCID https://orcid.org/0000-0001-9659-0049
Juliette-Laure N Ndzie OndiguiDepartment of Microbiology, Faculty of Sciences, University of Yaoundé 1, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0001-6569-3950
Jude S Y AtahAyos Health District, Komdombo Medicalised Health Centre, Ayos, Cameroon.ORCID https://orcid.org/0009-0005-8381-6623
Joseph Nelson Siewe FodjoBrain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.ORCID https://orcid.org/0000-0003-3544-1239
Patrick AwoumouDepartment of Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0003-4138-0399
Alliance-Laure OtamDepartment of Molecular Biology, Chantal BIYA International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.ORCID https://orcid.org/0009-0009-9837-3051
Martin N D MokakeBuea Regional Hospital Annex, Buea, Cameroon.ORCID https://orcid.org/0000-0003-3648-0571
Puinta PeyongaDepartment of Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.ORCID https://orcid.org/0009-0005-5467-3571
Rosi García Martinez PeñalverBikop Catholic Health Center, Bikop, Cameroon.ORCID https://orcid.org/0009-0006-0872-3571
Isabel Fernández EscobarBikop Catholic Health Center, Bikop, Cameroon.ORCID https://orcid.org/0009-0003-2890-8096
Desire AkabaDepartment of Anatomy, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0003-3319-2275
Felix AssahDepartment of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0003-3301-6028
Robinson Mbu EnowDepartment of Gynecology and Obstetrics, Yaoundé Gynecology, Obstetrics and Pediatrics Hospital, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0002-1190-6604
Judith N TorimiroDepartment of Molecular Biology, Chantal BIYA International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.ORCID https://orcid.org/0000-0003-3844-8428

Funding

TUBERCULOSIS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW000010 · FIC · JOHNS HOPKINS UNIVERSITY · PI BEYRER, CHRISTOPHER C. · 1988 to 2012
$19.8M
Antiretroviral Activity of TRIM5alphaR01AI063987 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SODROSKI, JOSEPH G · 2005 to 2014
$4.2M
Structure of the Retroviral Restriction Factor, TRIM5alphaR21AI076094 · NIAID · DANA-FARBER CANCER INST · PI SODROSKI, JOSEPH G · 2007 to 2008
$463k
FIC NIH HHS D43 TW000010NIAID NIH HHS R01 AI063987NIAID NIH HHS R21 AI076094
6 · The paper itself

Abstract

Background: In Cameroon, the prevalence of hepatitis B in the general population is 10%, and the vaccination coverage is less than 15% among adults. Although 80% have heard about the disease, only 50% know the modes of transmission and prevention of hepatitis B virus (HBV). Aim: To assess the knowledge, attitude and practice (KAP), sensitise the population and identify new cases of hepatitis B. Setting: Rural and urban areas of the Centre and South West Regions in Cameroon. Methods: An observational cross-sectional study was carried out from 2021 to 2023 on the general population to determine the HBV, seroprevalence and assess awareness of hepatitis B. We used modified Bloom's cutoff to define KAP categories. Results: Seven hundred and fifty-nine and 456 persons gave consent to participate in the KAP and sero-surveys, respectively. About 20.4% ( Conclusion: Poor knowledge and lack of access to reliable information enhance the spread of hepatitis B. This propagation could be mitigated through sensitisation, voluntary counselling and testing (VCT) to identify new cases. Contribution: Highlights community-engaging initiatives to sensitise, test, prevent and treat hepatitis B.

Indexed as

communitycounsellinghepatitis Bsensitisationtesting

Identifiers

PMID41069501
PMCPMC12505850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.